603229 奥翔药业
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产499,541-3.42%517,239265,934222,219222,878
在建工程541,5062.90%526,227685,009379,23877,041
无形资产148,865-1.00%150,366153,949156,17059,303
商誉0--0000
其他非流动资产86,4014.08%83,01373,73261,24542,539
1,276,313-0.04%1,276,8451,178,625818,871401,761

流动资产
货币资金989,376-12.00%1,124,230608,853564,555739,106
应收账款306,593130.95%132,751134,81266,24045,563
存货361,866-0.91%365,179320,565243,442190,169
其他流动资产46,484-11.57%52,56672,475146,3485,090
1,704,3191.77%1,674,7261,136,7051,020,584979,928

流动负债
短期借款200,256-33.31%300,260160,12065,07441,042
应付票据131,16619.51%109,754149,323201,76360,586
应付帐款250,165-16.91%301,094369,999200,482110,672
其他流动负债41,062-31.40%59,86065,98263,00431,570
622,649-19.24%770,968745,424530,323243,871
流动资产净值1,081,67119.69%903,758391,281490,261736,057
资产总额减流动负债2,357,9848.13%2,180,6031,569,9061,309,1331,137,818

非流动负债
长期借款0--072,74444,8590
应付债券0--0000
其他非流动负债36,560-6.32%39,02636,0219,45910,935
36,560-6.32%39,026108,76654,31810,935

总权益
    实收股本593,0690.00%593,069401,867287,048239,206
    储备项目1,728,35511.61%1,548,5071,059,274967,767887,676
股东权益2,321,4258.40%2,141,5771,461,1411,254,8151,126,882
非控股权益0--0000